Skip to content
Politically.com Search all
Menu

Final rule 2026-07366

Physical Medicine Devices; Reclassification of Non-Invasive Bone Growth Stimulators

The Food and Drug Administration (FDA) is issuing a final order to reclassify non-invasive bone growth stimulators (product codes LOF and LPQ), postamendments class III devices, into class II, subject to premarket notification. FDA is codifying the reclassification of these devices under the new classification regulation, "non-invasive bone growth stimulator." FDA is also establishing the special controls necessary to provide reasonable assurance of safety and effectiveness of these devices.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2026-07366
Published
Apr 16, 2026
Effective
May 18, 2026
Comments close
Not supplied
Federal Register citation
91 FR 20352

Docket identifiers

  • Docket No. FDA-2020-N-1053

CFR references

  • Title 21, part 890